Ameritas Investment Partners, Inc. - Y-MABS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,415
-19.7%
2,6450.0%0.00%0.0%
Q2 2023$17,960
+35.5%
2,6450.0%0.00%0.0%
Q1 2023$13,251
+13.1%
2,6450.0%0.00%–
Q4 2022$11,717
-69.2%
2,6450.0%0.00%
-100.0%
Q3 2022$38,000
-5.0%
2,6450.0%0.00%0.0%
Q2 2022$40,000
+29.0%
2,6450.0%0.00%
+100.0%
Q1 2022$31,000
-27.9%
2,6450.0%0.00%0.0%
Q4 2021$43,000
-42.7%
2,6450.0%0.00%
-66.7%
Q3 2021$75,000
-15.7%
2,6450.0%0.00%0.0%
Q2 2021$89,000
+11.2%
2,6450.0%0.00%0.0%
Q1 2021$80,000
-38.9%
2,6450.0%0.00%
-50.0%
Q4 2020$131,000
+28.4%
2,6450.0%0.01%
+20.0%
Q3 2020$102,000
-10.5%
2,6450.0%0.01%0.0%
Q2 2020$114,000
+115.1%
2,645
+30.4%
0.01%
+66.7%
Q1 2020$53,000
-15.9%
2,0290.0%0.00%0.0%
Q4 2019$63,000
+37.0%
2,029
+14.5%
0.00%
+50.0%
Q3 2019$46,000
+12.2%
1,7720.0%0.00%0.0%
Q2 2019$41,000
+173.3%
1,772
+208.2%
0.00%
+100.0%
Q1 2019$15,000
+25.0%
5750.0%0.00%0.0%
Q4 2018$12,000–575–0.00%–
 Download
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$932,9393.08%
Sofinnova Investments, Inc. 2,194,278$10,708,0770.64%
Artal Group S.A. 400,000$1,9520.11%
Polar Capital Holdings Plc 1,991,929$9,720,6140.08%
ASHFORD CAPITAL MANAGEMENT INC 98,870$482,4860.08%
Soleus Capital Management, L.P. 87,182$425,4480.06%
GSA CAPITAL PARTNERS LLP 99,160$4840.06%
Cormorant Asset Management, LP 150,000$7320.05%
CORNERCAP INVESTMENT COUNSEL INC 48,233$235,3770.04%
XTX Topco Ltd 38,574$188,2410.04%
View complete list of Y-MABS THERAPEUTICS INC shareholders